a few people working at a table

Press Releases

Ladenburg Thalmann Acts as Exclusive Financial Advisor to Aerpio Pharmaceuticals, Inc. (ARPO) in its Merger With Aadi Biosciences, Inc.

August 28, 2021

On August 26, 2021, Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) announced the completion of its merger with Aadi...

Ladenburg Thalmann Acts as Co-Manager for Immunic, Inc. (IMUX) in its $45.0 Million Follow-On Offering

Transaction Information Immunic, Inc. (Nasdaq: IMUX), announced the closing of its previously announced public...

Ladenburg Thalmann Acts as Lead Book-Running Manager for Applied UV, Inc. (AUVI) in its $12.0 Million Series A Cumulative Perpetual Preferred Stock Offering

Transaction Information Applied UV, Inc. (NASDAQ: AUVI) announced the closing of its underwritten registered...

Ladenburg Thalmann Acts as Co-Manager for Celsius Holdings, Inc. (CELH) in its $461.9 Million Follow-On Offering

Transaction Information Celsius Holdings, Inc. (NASDAQ: CELH), closed its previously announced public offering...

Ladenburg Thalmann Acts as Sole Book-Running Manager for electroCore, Inc. (ECOR) in its $20.7 Million Follow-On Offering

Transaction Information electroCore, Inc. (NASDAQ: ECOR) announced the closing of its previously announced...

Ladenburg Thalmann Acts as Co-Manager for ABC Pharma Co, Inc. (CELH) in its $461.9 Million Follow-On Offering

Transaction Information Celsius Holdings, Inc. (NASDAQ: CELH), closed its previously announced public offering...

Ladenburg Thalmann Acts as Exclusive Placement Agent for Jaguar Health, Inc. (JAGX) in its $10.8 Million Registered Direct Offering

Transaction Information Jaguar Health, Inc. (NASDAQ: JAGX) announced it has entered into a securities purchase...

Ladenburg Thalmann Acts as Co-Manager for SeaSpine Holdings Corporation (SPNE) in its $100.9 Million Follow-On Offering

Transaction Information SeaSpine Holdings Corporation (NASDAQ: SPNE) announced the pricing of its previously...

Ladenburg Thalmann Acts as Exclusive Placement Agent for Immunome, Inc. (IMNM) in its $27.0 Million Private Placement

Transaction Information Immunome, Inc. (NASDAQ: IMNM) announced it has entered into a definitive securities purchase...